Qiongfei Zhou

Jan 2, 2025 | sciencedirect.com | Roy Jiang |Mary M. Tomayko |Xenofon Baraliakos |Qiongfei Zhou

DC is entirely responsible for the content of this correspondence. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. DC performs consulting for Tonix Pharmaceuticals, Merck, UCB, Theravance, Teva, Virios, Vertex, and Axsome.